Cachet Pharmaceutical Co Ltd (002462) — Capital Reinvestment Ratio

Latest as of December 2025: 0.02x

Cachet Pharmaceutical Co Ltd (002462) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥459.95 Million) in capital expenditures (CN¥9.78 Million). See net asset quality index of Cachet Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥459.95 Million
CNY

Capital Expenditures

CN¥9.78 Million
CNY

Data as of

Dec 2025
Most recent filing

Cachet Pharmaceutical Co Ltd Capital Reinvestment Ratio (2008–2025)

This chart tracks Cachet Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check 002462 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Cachet Pharmaceutical Co Ltd (2008–2025)

Year-by-year Capital Reinvestment Ratio for Cachet Pharmaceutical Co Ltd from 2008 to 2025. For live market cap and broader valuation context, see Cachet Pharmaceutical Co Ltd (002462) market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.02x CN¥1.39 Billion CN¥22.79 Million ▼ -80.9%
2024 0.09x CN¥180.36 Million CN¥15.42 Million ▼ -31.5%
2023 0.12x CN¥1.60 Billion CN¥199.30 Million ▼ -53.8%
2021 0.27x CN¥913.13 Million CN¥246.96 Million ▲ +16.9%
2020 0.23x CN¥1.11 Billion CN¥257.99 Million ▼ -74.2%
2019 0.90x CN¥293.11 Million CN¥262.53 Million ▲ +168.1%
2016 0.33x CN¥116.30 Million CN¥38.86 Million ▼ -82.3%
2011 1.89x CN¥48.57 Million CN¥91.78 Million ▲ +48.4%
2009 1.27x CN¥50.12 Million CN¥63.83 Million ▲ +213.9%
2008 0.41x CN¥54.83 Million CN¥22.25 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow